| |
|
|
|
Fennec Pharmaceuticals Inc.  
|
|
4.7 -0.02 (-0%) |
04-18 16:00 |
|
Open: |
4.68 |
Pre close: |
4.72 |
Target:
|
6.26 
|
|
High: |
4.73 |
Low: |
4.44 |
Resistance:
|
5.36
5.93
|
|
Volume: |
117,294 |
Market Cap: |
94M |
Support:
|
4.44
3.69
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.70
|
MACD |
MACD(12,26):
|
-0.33  |
|
MA(20): |
4.88 |
Signal(12,26,9): |
-0.37 |
|
MA(100): |
6.27 |
Stochastic Oscillator |
%K(14,3):
|
23.64 |
|
MA(250): |
8.20 |
%D(3): |
21.16 |
|
Average Volume(K) |
3-Month: |
5163
|
52-Week |
High:
|
13.54 |
|
10-Days: |
6094 |
Low: |
4.44 |
|
RSI |
RSI(14):
|
34.81 |
Change(%): |
-64.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.520 |
Return on Equity (ttm) |
-42.9 |
Shares Out. (M) |
19.90 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-40.1 |
Shares Float (M) |
19.90 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
63.40 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.700 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.83 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.44 |
P/CF |
-11.94 |
|
|
|
|
|
|
